Trials / Conditions / Siewert Type I Adenocarcinoma of Esophagogastric Junction
Siewert Type I Adenocarcinoma of Esophagogastric Junction
3 registered clinical trials studyying Siewert Type I Adenocarcinoma of Esophagogastric Junction — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Oral TGF-beta Receptor I Inhibitor Vactosertib in SOC Chemoradiotherapy for Esophageal Adenocarcinoma NCT06044311 | Sakti Chakrabarti | Phase 2 |
| Completed | Morbidity and Mortality After Esophageal and Esophagogastric Junction Cancer Surgery NCT06277921 | P. Herzen Moscow Oncology Research Institute | — |
| Unknown | Classification of Adenocarcinoma of the Esophagogastric Junction NCT04151524 | St. James's Hospital, Ireland | — |